Search Results - "Majumdar, Anup K"

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant by Bergström, Mats, Hargreaves, Richard J, Burns, H.Donald, Goldberg, Michael R, Sciberras, David, Reines, Scott A, Petty, Kevin J, Ögren, Mattias, Antoni, Gunnar, Långström, Bengt, Eskola, Olli, Scheinin, Mika, Solin, Olof, Majumdar, Anup K, Constanzer, Marvin L, Battisti, Wendy P, Bradstreet, Thomas E, Gargano, Cynthia, Hietala, Jarmo

“…Aprepitant is a highly selective substance P (neurokinin 1 [NK 1] receptor) antagonist that significantly improves the pharmacotherapy of acute and delayed…”
Get full text

Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity by Shadle, Craig R., Lee, Yih, Majumdar, Anup K., Petty, Kevin J., Gargano, Cynthia, Bradstreet, Thomas E., Evans, Judith K., Blum, Robert A.

“…The NK1 receptor antagonist aprepitant (EMEND®), developed for use in combination with a 5HT3 receptor antagonist and a corticosteroid to prevent highly…”
Get full text

Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers by Majumdar, Anup K., Howard, Laura, Goldberg, Michael R., Hickey, Lisa, Constanzer, Marvin, Rothenberg, Paul L., Crumley, Tami M., Panebianco, Deborah, Bradstreet, Thomas E., Bergman, Arthur J., Waldman, Scott A., Greenberg, Howard E., Butler, Kathleen, Knops, A., De Lepeleire, Inge, Michiels, Nicole, Petty, Kevin J.

“…Aprepitant is the first NK1 receptor antagonist approved for use with corticosteroids and 5HT3 receptor antagonists to prevent chemotherapy‐induced nausea and…”
Get full text

Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma by Musson, Donald G, Birk, Kimberly L, Kitchen, Chester J, Zhang, Jin, Hsieh, John Y.K, Fang, Wei, Majumdar, Anup K, Rogers, John D

“…Ertapenem is a new once-a-day antibiotic with excellent coverage of common community gram negative and gram positive aerobes and anaerobes. It demonstrates…”
Get full text

Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone by McCrea, Jacqueline B., Majumdar, Anup K., Goldberg, Michael R., Iwamoto, Marian, Gargano, Cynthia, Panebianco, Deborah L., Hesney, Michael, Lines, Christopher R., Petty, Kevin J., Deutsch, Paul J., Murphy, M. Gail, Gottesdiener, Keith M., Goldwater, D. Ronald, Blum, Robert A.

“…Background Aprepitant is a neurokinin1 receptor antagonist that, in combination with a corticosteroid and a 5‐hydroxytryptamine3 receptor antagonist, has been…”
Get full text

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians by Nix, David E., Majumdar, Anup K., DiNubile, Mark J.

“…Ertapenem, a Group 1 carbapenem, is a once-a-day parenteral β-lactam antibiotic recently licensed in the USA and Europe. Monotherapy with ertapenem dosed as 1…”
Get full text

Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis by Mistry, Goutam C., Majumdar, Anup K., Swan, Suzanne, Sica, Domenic, Fisher, Alison, Xu, Yang, Hesney, Michael, Xi, Liwen, Wagner, John A., Deutsch, Paul J.

“…Ertapenem is a parenteral β‐lactam carbapenem antibiotic. This open‐label study examined the pharmacokinetics of single 1‐g intravenous doses of ertapenem,…”
Get full text

Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe by Majumdar, Anup K., McCrea, Jacqueline B., Panebianco, Deborah L., Hesney, Michael, Dru, James, Constanzer, Marvin, Goldberg, Michael R., Murphy, Gail, Gottesdiener, Keith M., Lines, Christopher R., Petty, Kevin J., Blum, Robert A.

“…Background Aprepitant is a neurokinin1 receptor antagonist that enhances prevention of chemotherapy‐induced nausea and vomiting when added to conventional…”
Get full text

Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam by Majumdar, Anup K., Yan, Kerri X., Selverian, Diana V., Barlas, Suna, Constanzer, Marvin, Dru, James, McCrea, Jacqueline B., Ahmed, Tuli, Frick, Glen S., Kraft, Walter K., Petty, Kevin J., Greenberg, Howard E.

“…Oral aprepitant 125 mg, an antiemetic and a moderate inhibitor of the metabolism of oral midazolam, was assessed for interaction with intravenous midazolam in…”
Get full text

Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects by Feuring, Martin, Lee, Yih, Orlowski, Laura H., Michiels, Nicole, De Smet, Marina, Majumdar, Anup K., Petty, Kevin J., Goldberg, Michael R., Murphy, M. Gail, Gottesdiener, Keith M., Hesney, Michael, Brackett, L. Ellen, Wehling, Martin

“…Aprepitant is a highly selective neurokinin‐1 receptor antagonist that, in combination with a corticosteroid and a 5‐hydroxytryptamine3 (5HT3) receptor…”
Get full text

Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks by Cutler, Neal R., Jhee, Stanford S., Majumdar, Anup K., McLaughlin, Debra, Brucker, Mary Jo, Carides, Alexandra D., Kramer, Mark S., Matzura-Wolfe, Deborah, Reines, Scott A., Goldberg, Michael R.

“…Gastric stasis during migraine attacks results in delayed absorption of several orally administered antimigraine agents. This study, as part of a larger trial,…”
Get full text

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians: Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem by NIX, David E, MAJUMDAR, Anup K, DINUBILE, Mark J

Get full text